Skip to main content
Clinical Trials/IRCT20160813029327N18
IRCT20160813029327N18
Recruiting
Phase 3

Evaluation of the Clinical Signs and symptoms of Pneumonia Following Metoclopramide administration in unconscious patients with nasogastric tube in the intensive care unit.

Islamic Azad University of Pharmaceutical Science0 sites32 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Not specified
Sponsor
Islamic Azad University of Pharmaceutical Science
Enrollment
32
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Islamic Azad University of Pharmaceutical Science

Eligibility Criteria

Inclusion Criteria

  • dysphagia following the loss of consciousness,in ICU patients.
  • Nasogastric tube requirement, more than 24 hours.

Exclusion Criteria

  • oesophageal disorder
  • signs and symptoms of pneumonia
  • pregnancy and lactation
  • histoy of Parkinson disease
  • contraindication of metoclopramide
  • drug interaction with metoclopramide
  • gastrointestinal disorders like:GI bleeding ,obstruction ,cancer and perforation .
  • gastrointestinal surgery.
  • presence of pheochromocytoma

Outcomes

Primary Outcomes

Not specified

Similar Trials